Have you heard of Eshbal Functional Food Inc. (TSXV:ESBL.V)? Here are five reasons why investors are starting to take notice:

1. Pioneering Gluten-Free Products

Eshbal offers innovative, high-quality gluten-free, vegan, low-carb, and better-for-you foods that resonate with today’s health-conscious consumers.

This article is being disseminated on behalf of Eshbal Functional Food Inc. a third-party issuer and is intended for informational purposes only.

2. Proven Market Success

With 18 years of operational success in Israel, the company continues to deliver steady growth and profitable results within its core business.

3. Strategic North American Expansion

The North American market represents ~40 per cent of the global gluten free market and Eshbal is preparing a U.S. launch of locally produced gluten-free pita bread—initially frozen, with ambient shelf-stable versions in development—will reduce costs and increase accessibility across foodservice and retail.

4. Strong Recent Financial Performance

As a leading brand in Israel Q1 2025 delivered record revenues and gross profits, with a nearly 10 per cent year-over-year growth in revenue, a 21 per cent jump in gross profit, and improved operating margins.

5. Accelerated Growth via Acquisitions and Leadership Upgrades

Eshbal just signed its first binding LOI to acquire a majority stake (55 per cent) in Dare to Be Different Foods, a New York-based gluten-free brand, and appointed Avi Markus as Chief Commercial Officer for North America—enhancing distribution and executive strength.

With a track record of market success, proven financial momentum, significant U.S. expansion underway, and key strategic moves in motion—Eshbal is rapidly evolving into a global player in health-focused nutrition.

Curious to learn more? Visit eshbalfoods.com.

Join the discussion: Find out what everybody’s saying about this stock on the Eshbal Functional Food Inc. Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.

More From The Market Online

@ the Bell: TSX hits new record high, only to close lower

Canada’s top stock index came out of the gate hot on Friday to close out the...

@ the Bell: Oracle’s earnings miss sparks tech selloff

Canada’s top stock index rallied on Thursday despite renewed concerns over inflated technology valuations—sparked by Oracle’s...

Market Open: Disney Pops on AI Deal, Broadcom Slides on Backlog Concerns | Dec 12

TSX rises 0.54%, Nasdaq falls 1.10%, gold hits two-month high, oil and Bitcoin drop. Disney gains on AI deal while Broadcom slides on backlog…
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New stores, new shipments, new vapes

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks